Caricamento...
Hemophilia gene therapy comes of age
Concurrent with the development of recombinant factor replacement products, the characterization of the F9 and F8 genes over 3 decades ago allowed for the development of recombinant factor products and made the hemophilias a target disease for gene transfer. The progress of hemophilia gene therapy h...
Salvato in:
| Pubblicato in: | Blood Adv |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728634/ https://ncbi.nlm.nih.gov/pubmed/29296912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009878 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|